Poland - Zamość: Pharmaceutical products

Release

ID: ocds-pyfy63:2020-455874:2021-066519
Buyer: Samodzielny Publiczny Szpital Wojewódzki im. Papieża Jana Pawła II w Zamościu
Date: 2021-02-09
Language: PL
Tags: award

Release in JSON

Process

ID (OCID): ocds-pyfy63:2020-455874
Releases: 2020-09-29 (ocds-pyfy63:2020-455874:2020-455874)
2020-11-02 (ocds-pyfy63:2020-455874:2020-521747)
2020-11-11 (ocds-pyfy63:2020-455874:2020-540266)
2021-02-09 (ocds-pyfy63:2020-455874:2021-066519)

Releases in JSON

Tender

Title: Poland - Zamość: Pharmaceutical products
Award criteria: priceOnly
Award criteria details: Lowest price

Award criteria for item 1:
- Price

Award criteria for item 2:
- Price

Award criteria for item 3:
- Price

Award criteria for item 4:
- Price

Award criteria for item 5:
- Price

Award criteria for item 6:
- Price

Award criteria for item 7:
- Price

Award criteria for item 8:
- Price

Award criteria for item 9:
- Price

Award criteria for item 10:
- Price

Award criteria for item 11:
- Price

Award criteria for item 12:
- Price

Award criteria for item 13:
- Price

Award criteria for item 14:
- Price

Award criteria for item 15:
- Price

Award criteria for item 16:
- Price

Award criteria for item 17:
- Price

Award criteria for item 18:
- Price

Award criteria for item 19:
- Price

Award criteria for item 20:
- Price

Award criteria for item 21:
- Price

Award criteria for item 22:
- Price

Award criteria for item 23:
- Price

Award criteria for item 24:
- Price

Award criteria for item 25:
- Price

Award criteria for item 26:
- Price

Award criteria for item 27:
- Price

Award criteria for item 28:
- Price

Award criteria for item 29:
- Price

Award criteria for item 30:
- Price

Award criteria for item 31:
- Price

Award criteria for item 32:
- Price

Award criteria for item 33:
- Price

Award criteria for item 34:
- Price

Award criteria for item 35:
- Price

Award criteria for item 36:
- Price

Award criteria for item 37:
- Price

Award criteria for item 38:
- Price

Award criteria for item 39:
- Price

Award criteria for item 40:
- Price

Award criteria for item 41:
- Price

Award criteria for item 42:
- Price

Award criteria for item 43:
- Price

Award criteria for item 44:
- Price

Award criteria for item 45:
- Price

Award criteria for item 46:
- Price

Award criteria for item 47:
- Price

Award criteria for item 48:
- Price

Award criteria for item 49:
- Price

Award criteria for item 50:
- Price

Award criteria for item 51:
- Price

Award criteria for item 52:
- Price

Award criteria for item 53:
- Price

Award criteria for item 54:
- Price

Award criteria for item 55:
- Price

Award criteria for item 56:
- Price

Award criteria for item 57:
- Price

Award criteria for item 58:
- Price

Award criteria for item 59:
- Price

Award criteria for item 60:
- Price

Award criteria for item 61:
- Price

Award criteria for item 62:
- Price

Award criteria for item 63:
- Price

Award criteria for item 64:
- Price

Award criteria for item 65:
- Price
Main procurement category: goods
Procurement method: open
Procurement method details: Open procedure
Tender period: 2021-02-09 - ?
Tenderers: Asclepios S.A.
Urtica Sp. z o.o.
Polska Grupa Farmaceutyczna S.A.
Roche Polska Sp. z o.o.
Janssen - Cilag Polska Sp. z o.o.
Salus International Sp. z o.o.
Takeda Pharma Sp. z o.o.
Bialmed Sp. z o.o.
Pfizer Polska Sp. z o.o.
Servier Polska Services Sp. z o.o.
Genesis Pharm Sp. z o.o. Sp. k.
Delfarma Sp. z o.o.
Sanofi - Aventis Sp. z o.o.

Tender item

ID: ocds-pyfy63:2020-455874:obj:1
Classification: CPV / 33600000
Description: Poz. 1–5 – Fluorouracyl – 900 op., poz. 2–5 – Fluorouracyl – 100 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:2
Classification: CPV / 33600000
Description: Nab-paclitaxel – 400 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:3
Classification: CPV / 33600000
Description: Netupitant, palonosetron hydrochloride – 20 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:4
Classification: CPV / 33600000
Description: Cytarabina – 30 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:5
Classification: CPV / 33600000
Description: Anagrelidum – 40 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:6
Classification: CPV / 33600000
Description: Darbepoetyna alfa – 80 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:7
Classification: CPV / 33600000
Description: Poz. 1 – Bewacizumab – 300 op., poz. 2 – Bewacizumab – 300 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:8
Classification: CPV / 33600000
Description: Bicalutamid – 20 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:9
Classification: CPV / 33600000
Description: Bicalutamid – 20 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:10
Classification: CPV / 33600000
Description: Bleomycyna – 150 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:11
Classification: CPV / 33600000
Description: Doksorubicyna liposomalna pegylowana – 150 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:12
Classification: CPV / 33600000
Description: Poz. 1 – kwas folinowy – 500 op., poz. 2 – kwas folinowy – 150 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:13
Classification: CPV / 33600000
Description: Poz. 1 – Kapecytabina – 70 op., poz. 2 – Kapecytabina – 50 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:14
Classification: CPV / 33600000
Description: Poz. 1 – Karboplatyna – 300 op., poz. 2 – Karboplatyna – 300 op., poz. 3 – Karboplatyna – 150 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:15
Classification: CPV / 33600000
Description: Cisplatyna – 900 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:16
Classification: CPV / 33600000
Description: Poz. 1 – Dakarbazyna – 13 op., poz. 2 – Dakarbazyna – 15 op., poz. 3 – Dakarbazyna – 20 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:17
Classification: CPV / 33600000
Description: Dexamethasone phosphate – 100 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:18
Classification: CPV / 33600000
Description: Poz. 1 – Docetaksel – 300 op., poz. 2 – Docetaksel – 100 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:19
Classification: CPV / 33600000
Description: Doksorubicyna – 400 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:20
Classification: CPV / 33600000
Description: Poz. 1 – Cyklofosfamid – 460 op., poz. 2 – Cyklofosfamid – 60 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:21
Classification: CPV / 33600000
Description: Cyklofosfamid – 20 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:22
Classification: CPV / 33600000
Description: Wedolizumab – 60 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:23
Classification: CPV / 33600000
Description: Poz. 1 – Epirubicyna – 120 op., poz. 2 – Epirubicyna – 80 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:24
Classification: CPV / 33600000
Description: Poz. 1 – Cetuximab – 500 op., poz. 2 – Cetuximab – 320 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:25
Classification: CPV / 33600000
Description: Poz. 1 – Etopozyd – 400 op., poz. 2 – Etopozyd – 100 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:26
Classification: CPV / 33600000
Description: Fulvestrant – 220 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:27
Classification: CPV / 33600000
Description: Infliximab – 130 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:28
Classification: CPV / 33600000
Description: Poz. 1 – Gemcytabina – 150 op., poz. 2 – Gemcytabina – 280 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:29
Classification: CPV / 33600000
Description: Afatynib – 230 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:30
Classification: CPV / 33600000
Description: Trastuzumab – 230 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:31
Classification: CPV / 33600000
Description: Poz. 1 – Trastuzumab – 500 op., poz. 2 – Trastuzumab – 150 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:32
Classification: CPV / 33600000
Description: Poz. 1 – Ifosfamid – 40 op., poz. 2 – Ifosfamid – 40 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:33
Classification: CPV / 33600000
Description: Palbocyclib – 27 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:34
Classification: CPV / 33600000
Description: Poz. 1 – Irinotecan hydrochloridum – 400 op., poz. 2 – Irinotecan hydrochloridum – 250 op., poz. 3 – Irinotecan hydrochloridum – 300 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:35
Classification: CPV / 33600000
Description: Poz. 1 – Trastuzumab emtanzyna – 170 op., poz. 2 – Trastuzumab emtanzyna – 40 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:36
Classification: CPV / 33600000
Description: Pembrolizumab – 130 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:37
Classification: CPV / 33600000
Description: Acidum levofolinicum – 200 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:38
Classification: CPV / 33600000
Description: Trifluridine, Tipiracil hydrochloride – 110 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:39
Classification: CPV / 33600000
Description: Trifluridine, Tipiracil hydrochloride – 35 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:40
Classification: CPV / 33600000
Description: Trifluridine, Tipiracil hydrochloride – 50 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:41
Classification: CPV / 33600000
Description: Trifluridine, Tipiracil hydrochloride – 80 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:42
Classification: CPV / 33600000
Description: Poz. 1 – Rituximab – 30 op., poz. 2 – Rituximab – 70 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:43
Classification: CPV / 33600000
Description: Rituximab – 50 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:44
Classification: CPV / 33600000
Description: Poz. 1 – Metotrexat – 10 op., poz. 2 – Metotrexat – 30 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:45
Classification: CPV / 33600000
Description: Mitomicyna – 10 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:46
Classification: CPV / 33600000
Description: Mitoxantron – 10 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:47
Classification: CPV / 33600000
Description: Vinorelbina – 600 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:48
Classification: CPV / 33600000
Description: Poz. 1 – Vinorelbina – 60 op., poz. 2 – Vinorelbina – 40 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:49
Classification: CPV / 33600000
Description: Ondansetron – 1 500 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:50
Classification: CPV / 33600000
Description: Poz. 1 – Nivolumab – 300 op., poz. 2 – Nivolumab – 150 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:51
Classification: CPV / 33600000
Description: Poz. 1 – Oxaliplatyna – 500 op., poz. 2 – Oxaliplatyna – 400 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:52
Classification: CPV / 33600000
Description: Poz. 1 – Paclitaxel – 240 op., poz. 2 – Paclitaxel – 280 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:53
Classification: CPV / 33600000
Description: Poz. 1 – Pemetrexed – 140 op., poz. 2 – Pemetrexed – 40 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:54
Classification: CPV / 33600000
Description: Pertuzumab – 120 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:55
Classification: CPV / 33600000
Description: Oktreotyd – 20 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:56
Classification: CPV / 33600000
Description: Lanreotyd – 12 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:57
Classification: CPV / 33600000
Description: Atezolizumab – 40 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:58
Classification: CPV / 33600000
Description: Poz. 1 – Temozolomid – 700 op., poz. 2 – Temozolomid – 700 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:59
Classification: CPV / 33600000
Description: Poz. 1 – Topotekan – 50 op., poz. 2 – Topotekan – 20 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:60
Classification: CPV / 33600000
Description: Mesna – 30 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:61
Classification: CPV / 33600000
Description: Poz. 1 – Panitumumab – 45 op., poz. 2 – Panitumumab – 40 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:62
Classification: CPV / 33600000
Description: Vinkrystyna – 130 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:63
Classification: CPV / 33600000
Description: Poz. 1 – Aflibercept – 20 op., poz. 2 – Aflibercept – 20 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:64
Classification: CPV / 33600000
Description: Adalimumab – 15 op.

Tender item

ID: ocds-pyfy63:2020-455874:obj:65
Classification: CPV / 33600000
Description: Filgrastym – 250 op.

Award

ID: ocds-pyfy63:2020-455874:award:0
Title: Zadanie 1
Date: 2021-01-15
Status: active
Suppliers: Asclepios S.A.

Award

ID: ocds-pyfy63:2020-455874:award:1
Title: Zadanie 2
Status: unsuccessful

Award

ID: ocds-pyfy63:2020-455874:award:2
Title: Zadanie 3
Date: 2021-01-15
Status: active
Suppliers: Urtica Sp. z o.o.
Polska Grupa Farmaceutyczna S.A.

Award

ID: ocds-pyfy63:2020-455874:award:3
Title: Zadanie 4
Date: 2021-01-15
Status: active
Suppliers: Asclepios S.A.

Award

ID: ocds-pyfy63:2020-455874:award:4
Title: Zadanie 5
Date: 2021-01-15
Status: active
Suppliers: Asclepios S.A.

Award

ID: ocds-pyfy63:2020-455874:award:5
Title: Zadanie 6
Status: unsuccessful

Award

ID: ocds-pyfy63:2020-455874:award:6
Title: Zadanie 7
Date: 2021-01-15
Status: active
Suppliers: Roche Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2020-455874:award:7
Title: Zadanie 8
Date: 2021-01-15
Status: active
Suppliers: Urtica Sp. z o.o.
Polska Grupa Farmaceutyczna S.A.

Award

ID: ocds-pyfy63:2020-455874:award:8
Title: Zadanie 9
Date: 2021-01-15
Status: active
Suppliers: Urtica Sp. z o.o.
Polska Grupa Farmaceutyczna S.A.

Award

ID: ocds-pyfy63:2020-455874:award:9
Title: Zadanie 10
Date: 2021-01-15
Status: active
Suppliers: Asclepios S.A.

Award

ID: ocds-pyfy63:2020-455874:award:10
Title: Zadanie 11
Date: 2021-01-15
Status: active
Suppliers: Janssen - Cilag Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2020-455874:award:11
Title: Zadanie 12
Date: 2021-01-15
Status: active
Suppliers: Asclepios S.A.

Award

ID: ocds-pyfy63:2020-455874:award:12
Title: Zadanie 13
Date: 2021-01-15
Status: active
Suppliers: Salus International Sp. z o.o.

Award

ID: ocds-pyfy63:2020-455874:award:13
Title: Zadanie 14
Date: 2021-01-14
Status: active
Suppliers: Asclepios S.A.

Award

ID: ocds-pyfy63:2020-455874:award:14
Title: Zadanie 15
Date: 2021-01-15
Status: active
Suppliers: Asclepios S.A.

Award

ID: ocds-pyfy63:2020-455874:award:15
Title: Zadanie 16
Date: 2021-01-15
Status: active
Suppliers: Salus International Sp. z o.o.

Award

ID: ocds-pyfy63:2020-455874:award:16
Title: Zadanie 17
Date: 2021-01-15
Status: active
Suppliers: Urtica Sp. z o.o.
Polska Grupa Farmaceutyczna S.A.

Award

ID: ocds-pyfy63:2020-455874:award:17
Title: Zadanie 18
Date: 2021-01-15
Status: active
Suppliers: Asclepios S.A.

Award

ID: ocds-pyfy63:2020-455874:award:18
Title: Zadanie 19
Date: 2021-01-15
Status: active
Suppliers: Asclepios S.A.

Award

ID: ocds-pyfy63:2020-455874:award:19
Title: Zadanie 20
Date: 2021-01-15
Status: active
Suppliers: Salus International Sp. z o.o.

Award

ID: ocds-pyfy63:2020-455874:award:20
Title: Zadanie 21
Date: 2021-01-15
Status: active
Suppliers: Salus International Sp. z o.o.

Award

ID: ocds-pyfy63:2020-455874:award:21
Title: Zadanie 22
Date: 2021-01-15
Status: active
Suppliers: Takeda Pharma Sp. z o.o.

Award

ID: ocds-pyfy63:2020-455874:award:22
Title: Zadanie 23
Date: 2021-01-15
Status: active
Suppliers: Asclepios S.A.

Award

ID: ocds-pyfy63:2020-455874:award:23
Title: Zadanie 24
Date: 2021-01-15
Status: active
Suppliers: Urtica Sp. z o.o.
Polska Grupa Farmaceutyczna S.A.

Award

ID: ocds-pyfy63:2020-455874:award:24
Title: Zadanie 25
Date: 2021-01-15
Status: active
Suppliers: Asclepios S.A.

Award

ID: ocds-pyfy63:2020-455874:award:25
Title: Zadanie 26
Date: 2021-01-15
Status: active
Suppliers: Urtica Sp. z o.o.
Polska Grupa Farmaceutyczna S.A.

Award

ID: ocds-pyfy63:2020-455874:award:26
Title: Zadanie 27
Date: 2021-01-15
Status: active
Suppliers: Asclepios S.A.

Award

ID: ocds-pyfy63:2020-455874:award:27
Title: Zadanie 28
Date: 2021-01-15
Status: active
Suppliers: Asclepios S.A.

Award

ID: ocds-pyfy63:2020-455874:award:28
Title: Zadanie 29
Date: 2021-01-15
Status: active
Suppliers: Urtica Sp. z o.o.
Polska Grupa Farmaceutyczna S.A.

Award

ID: ocds-pyfy63:2020-455874:award:29
Title: Zadanie 30
Date: 2021-01-15
Status: active
Suppliers: Roche Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2020-455874:award:30
Title: Zadanie 31
Date: 2021-01-15
Status: active
Suppliers: Bialmed Sp. z o.o.

Award

ID: ocds-pyfy63:2020-455874:award:31
Title: Zadanie 32
Date: 2021-01-15
Status: active
Suppliers: Salus International Sp. z o.o.

Award

ID: ocds-pyfy63:2020-455874:award:32
Title: Zadanie 33
Date: 2021-01-15
Status: active
Suppliers: Pfizer Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2020-455874:award:33
Title: Zadanie 34
Date: 2021-01-15
Status: active
Suppliers: Urtica Sp. z o.o.
Polska Grupa Farmaceutyczna S.A.

Award

ID: ocds-pyfy63:2020-455874:award:34
Title: Zadanie 35
Date: 2021-01-15
Status: active
Suppliers: Roche Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2020-455874:award:35
Title: Zadanie 36
Status: unsuccessful

Award

ID: ocds-pyfy63:2020-455874:award:36
Title: Zadanie 37
Date: 2021-01-15
Status: active
Suppliers: Salus International Sp. z o.o.

Award

ID: ocds-pyfy63:2020-455874:award:37
Title: Zadanie 38
Date: 2021-01-15
Status: active
Suppliers: Servier Polska Services Sp. z o.o.

Award

ID: ocds-pyfy63:2020-455874:award:38
Title: Zadanie 39
Date: 2021-01-15
Status: active
Suppliers: Servier Polska Services Sp. z o.o.

Award

ID: ocds-pyfy63:2020-455874:award:39
Title: Zadanie 40
Date: 2021-01-15
Status: active
Suppliers: Servier Polska Services Sp. z o.o.

Award

ID: ocds-pyfy63:2020-455874:award:40
Title: Zadanie 41
Date: 2021-01-15
Status: active
Suppliers: Servier Polska Services Sp. z o.o.

Award

ID: ocds-pyfy63:2020-455874:award:41
Title: Zadanie 42
Date: 2021-01-15
Status: active
Suppliers: Urtica Sp. z o.o.
Polska Grupa Farmaceutyczna S.A.

Award

ID: ocds-pyfy63:2020-455874:award:42
Title: Zadanie 43
Status: unsuccessful

Award

ID: ocds-pyfy63:2020-455874:award:43
Title: Zadanie 44
Date: 2021-01-15
Status: active
Suppliers: Asclepios S.A.

Award

ID: ocds-pyfy63:2020-455874:award:44
Title: Zadanie 45
Date: 2021-01-15
Status: active
Suppliers: Genesis Pharm Sp. z o.o. Sp. k.

Award

ID: ocds-pyfy63:2020-455874:award:45
Title: Zadanie 46
Date: 2021-01-15
Status: active
Suppliers: Genesis Pharm Sp. z o.o. Sp. k.

Award

ID: ocds-pyfy63:2020-455874:award:46
Title: Zadanie 47
Date: 2021-01-15
Status: active
Suppliers: Asclepios S.A.

Award

ID: ocds-pyfy63:2020-455874:award:47
Title: Zadanie 48
Status: unsuccessful

Award

ID: ocds-pyfy63:2020-455874:award:48
Title: Zadanie 49
Status: unsuccessful

Award

ID: ocds-pyfy63:2020-455874:award:49
Title: Zadanie 50
Date: 2021-01-15
Status: active
Suppliers: Urtica Sp. z o.o.
Polska Grupa Farmaceutyczna S.A.

Award

ID: ocds-pyfy63:2020-455874:award:50
Title: Zadanie 51
Date: 2021-01-15
Status: active
Suppliers: Urtica Sp. z o.o.
Polska Grupa Farmaceutyczna S.A.

Award

ID: ocds-pyfy63:2020-455874:award:51
Title: Zadanie 52
Date: 2021-01-15
Status: active
Suppliers: Bialmed Sp. z o.o.

Award

ID: ocds-pyfy63:2020-455874:award:52
Title: Zadanie 53
Date: 2021-01-15
Status: active
Suppliers: Urtica Sp. z o.o.
Polska Grupa Farmaceutyczna S.A.

Award

ID: ocds-pyfy63:2020-455874:award:53
Title: Zadanie 54
Date: 2021-01-15
Status: active
Suppliers: Roche Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2020-455874:award:54
Title: Zadanie 55
Date: 2021-01-15
Status: active
Suppliers: Urtica Sp. z o.o.
Polska Grupa Farmaceutyczna S.A.

Award

ID: ocds-pyfy63:2020-455874:award:55
Title: Zadanie 56
Date: 2021-01-15
Status: active
Suppliers: Urtica Sp. z o.o.
Polska Grupa Farmaceutyczna S.A.

Award

ID: ocds-pyfy63:2020-455874:award:56
Title: Zadanie 57
Date: 2021-01-15
Status: active
Suppliers: Roche Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2020-455874:award:57
Title: Zadanie 58
Date: 2021-01-15
Status: active
Suppliers: Urtica Sp. z o.o.
Polska Grupa Farmaceutyczna S.A.

Award

ID: ocds-pyfy63:2020-455874:award:58
Title: Zadanie 59
Date: 2021-01-15
Status: active
Suppliers: Salus International Sp. z o.o.

Award

ID: ocds-pyfy63:2020-455874:award:59
Title: Zadanie 60
Date: 2021-01-15
Status: active
Suppliers: Delfarma Sp. z o.o.

Award

ID: ocds-pyfy63:2020-455874:award:60
Title: Zadanie 61
Status: unsuccessful

Award

ID: ocds-pyfy63:2020-455874:award:61
Title: Zadanie 62
Date: 2021-01-15
Status: active
Suppliers: Urtica Sp. z o.o.
Polska Grupa Farmaceutyczna S.A.

Award

ID: ocds-pyfy63:2020-455874:award:62
Title: Zadanie 63
Date: 2021-01-15
Status: active
Suppliers: Sanofi - Aventis Sp. z o.o.

Award

ID: ocds-pyfy63:2020-455874:award:63
Title: Zadanie 64
Date: 2021-01-15
Status: active
Suppliers: Asclepios S.A.

Award

ID: ocds-pyfy63:2020-455874:award:64
Title: Zadanie 65
Date: 2021-01-15
Status: active
Suppliers: Urtica Sp. z o.o.
Polska Grupa Farmaceutyczna S.A.

Parties

Roles: buyer
Organization name: Samodzielny Publiczny Szpital Wojewódzki im. Papieża Jana Pawła II w Zamościu
Street address: Al. Jana Pawła II 10
Locality: Zamość
Postal code: 22-400
Country: PL
E-mail: zamowienia@szpital.zam.pl
Phone: +48 846773329
Fax: +48 846386669
Website: www.szpital.zam.pl